Alamo Pharma Services, Inc. Chief Operating Officer, Peter Marchesini (right), participates in the panel discussion, “Off Label Developments: The Future of Product Communications,” at the recent FDA/CMS Summit in Washington, D.C. Marchesini was joined in the panel by moderator M. Nielsen Hobbs, editor of The Pink Sheet (left), and Kevin Ryan, Senior Director, Compliance and Ethics at Novo Nordisk (center).
Alamo Pharma Services, Inc. Chief Operating Officer, Peter Marchesini (right), participates in the panel discussion, “Off Label Developments: The Future of Product Communications,” at the recent FDA/CMS Summit in Washington, D.C. Marchesini was joined in the panel by moderator M. Nielsen Hobbs, editor of The Pink Sheet (left), and Kevin Ryan, Senior Director, Compliance and Ethics at Novo Nordisk (center).